Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03795194 · ClinicalTrials.gov registry record · Phase 4
Antibiotic Duration in Post-appendectomy Abscess
A Phase 4 study, sponsored by Phoenix Children's Hospital.
- Terminated
- Registry status
- Phase 4
- Development phase
- 7
- Enrollment target
NCT03795194: Clinical Trial Phase 4 study, sponsored by Phoenix Children's Hospital.
NCT03795194 is a Phase 4 study that was terminated before completion, run by Phoenix Children's Hospital. The registered enrollment target is 7 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03795194, a Phase 4 study, was terminated before completion, sponsored by Phoenix Children's Hospital.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 7 participants
- Enrollment target
Study Summary
This is a randomized study of patients 2-17 years old who are diagnosed with perforated appendicitis and develop an abscess after laparoscopy that is subsequently drained. Patients will be randomized to either receive an 8-day or a 4-day course of antibiotics. The aim of this study is to determine whether duration of antibiotic treatment at discharge demonstrates significant differences in clinical outcomes.
Primary Outcome
Rate of readmission to the hospital after abscess drainage.
Interventions
- DRUG ampicillin/clavulanate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2019-05-01 |
| Est. Completion | 2021-12-15 |
| Phase | Phase 4 |
Why NCT03795194 stopped before completion
NCT03795194 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which ampicillin/clavulanate is the first listed.
NCT03795194 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03795194 about?
NCT03795194 is a clinical study titled "Antibiotic Duration in Post-appendectomy Abscess". This is a randomized study of patients 2-17 years old who are diagnosed with perforated appendicitis and develop an abscess after laparoscopy that is subsequently drained. Patients will be randomized to either receive an 8-day or a 4-day course of antibiotics. The aim of this study is to determine w...
What is the current status of trial NCT03795194?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 7 participants. The study started on 2019-05-01. Estimated completion is 2021-12-15.
What interventions are being tested in trial NCT03795194?
The interventions under investigation include: ampicillin/clavulanate (DRUG).
Who is sponsoring clinical trial NCT03795194?
This trial is sponsored by Phoenix Children's Hospital, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03795194's enrollment target sits among peer trials
7 1981st of 2000 higher than 18 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI